ReviewEndocrinology and metabolism (Seoul, Korea)2019

The Role of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Reducing Cardiovascular Events in Patients with Type 2 Diabetes.

Gwang Sil Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.